Figure 3.
Figure 3. Schedules of rituximab used as single agent to consolidate or prolong remission. . / . / 375 mg/m2 weekly, wk 1–4, 2 months after end of induction (29). / 375 mg/m2 weekly, wk 1–4, every 6 months for 3 times (10). / 375 mg/m2 at month 2, 4, 6, 8 after end of induction (13). / 375 mg/m2 every 3 months for 2 years (24). / 375 mg/m2 every time the rituximab blood levels falls under 25 mg/mL (16). / 375 mg/m2 every 2 months for 2 years (ongoing PRIMA study)

Schedules of rituximab used as single agent to consolidate or prolong remission.

  • 375 mg/m2 weekly, wk 1–4, 2 months after end of induction (29)

  • 375 mg/m2 weekly, wk 1–4, every 6 months for 3 times (10)

  • 375 mg/m2 at month 2, 4, 6, 8 after end of induction (13)

  • 375 mg/m2 every 3 months for 2 years (24)

  • 375 mg/m2 every time the rituximab blood levels falls under 25 mg/mL (16)

  • 375 mg/m2 every 2 months for 2 years (ongoing PRIMA study)

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal